{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P19440",
      "entity_text" : "gGT",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_Y548" ],
      "TissueType" : [ "tissuelist:TS-0564" ],
      "Organ" : [ "uberon:UBERON:0006611" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Levels of gGT, a marker of liver dysfunction, were significantly reduced in GFT505 versus placebo patients (S1 effect size -19.9% [95% one sided CI -infinity to -12.8], P < 0.0001; S2 -15.1% [-infinity to -1.1], P = 0.004).",
  "reading_complete" : "2020-07-28T12:01:24Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:54:55Z",
  "trigger" : "Levels",
  "evidence" : [ "Levels of gGT" ],
  "pmc_id" : "3161281",
  "score" : 0
}